Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 2,627 | 4,642 | 4,071 | 1,474 | 1,092 |
Operating Income | -2,627 | -4,642 | -4,071 | -1,474 | -1,092 |
Other Income | 0 | 0 | 67 | 0 | -1 |
Pre-tax Income | -2,627 | -4,642 | -4,004 | -1,474 | -1,093 |
Net Income Continuous | -2,627 | -4,642 | -4,004 | -1,474 | -1,093 |
Net Income | $-2,627 | $-4,642 | $-4,004 | $-1,474 | $-1,093 |
EPS Basic Total Ops | -0.25 | -0.46 | -0.57 | -0.21 | -0.16 |
EPS Basic Continuous Ops | -0.25 | -0.46 | -0.57 | -0.21 | -0.16 |
EPS Diluted Total Ops | -0.25 | -0.46 | -0.57 | -0.21 | -0.16 |
EPS Diluted Continuous Ops | -0.25 | -0.46 | -0.57 | -0.21 | -0.16 |
EBITDA(a) | $-2,627 | $-4,642 | $-4,071 | $-1,474 | $-1,092 |